Johnathan Cohen., Founder, and Chief Executive Officer, 20/20 GeneSystems Inc. joins Rich Bendis to discuss cancer diagnostics, crowdfunding, and where his company is headed. Under Mr. Cohen’s leadership, 20/20 GeneSystems has brought in approximately $7.5 million in grant funding and launched two successful products, a kit for suspicious powders used by hundreds of emergency responder organizations worldwide and a blood test for the early detection of lung cancer.
Latest posts by Chris Frew (see all)
- Dr. Christine Dingivan Joins Emmes as President and CEO - September 24, 2020
- Gary Nabors, Ph.D. Joins Integrated BioTherapeutics Inc. as Executive Vice President and Chief Development Officer - September 24, 2020
- ABL Inc. Announces Hiring of Diana Elias as HR Director - September 24, 2020